Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Avacopan by Amgen for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis): Likelihood of Approval
Avacopan is under clinical development by Amgen and currently in Phase III for Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis (ANCA Vasculitis). According...
Data Insights
Avacopan by Amgen for Systemic Lupus Erythematosus: Likelihood of Approval
Avacopan is under clinical development by Amgen and currently in Phase I for Systemic Lupus Erythematosus. According to GlobalData, Phase...